Holding(s) in Company

RNS Number : 8099Q

Evgen Pharma PLC

23 June 2020

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Evgen Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	change in percentage of voting rights arising upon a new issue of shares by the issuer
3. Full name of person(s) subject to the notification obligation: iii		Enterprise Ventures Limited
4. Full name of shareholder(s)  (if different from 3.):iv		South Yorkshire Investment Fund Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v		19th June 2020
6. Date on which issuer notified:		23rd June 2020
7. Threshold(s) that is/are crossed or reached: vi, vii		2%

 

8. Notified details:

A: Voting rights attached to sharesviii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct xi

Indirecti

Direct

Indirect

GB00BSVYN304

2,777,776

2,777,776

1,394,550

1,394,550

Nil

1.05

Nil

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

None

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,394,550

1.05%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:	Enterprise Ventures Limited
15. Contact telephone number:	01772 270 570

 

END

 

 

HOLFZGZVGFDGGZM